×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
Enhancing the Science of Patient Engagement and Patient Input: What's in the Future?
Session Chair(s)
Pujita Vaidya, MPH
North America Lead, Regulatory Science and Policy
Sanofi, United States
This forum discussion focuses on current state, challenges, and opportunities to enhancing the science of patient input. Panel of experts will discuss examples of approaches with partnering with patients, enanging regulators and measuring progress.
Learning Objective : Discuss approaches and best practices for partnering and co-creating with patients; Identify strategies to systematically incorporate patient input into decision making; Describe opportunities to enhance interactions between industry and regulators; Discuss approaches to measure progress in engaging patients and its impact to medical product development.
Speaker(s)
FDA Perspective
Robyn Bent, BSN, MS, RN
FDA, United States
Director, Patient Focused Drug Development, OCD, CDER
Industry Perspective and Case Example
Elizabeth Rosenkrands-Lange, MPH, MS
EMD Serono, Part of Merck KGaA, Darmstadt, Germany, United States
Senior Director/ Head of US Regulatory Scientific Policy
Patient Researcher Perspective
Bellinda King-Kallimanis, PhD, MSc
Lungevity Foundation, United States
Senior Director of Patient-Focused Research
Have an account?